Increased serum concentrations of secondary bile salts during cholate feeding are due to coprophagy. A study with wild-type and Atp8b1-deficient mice

Molecular Pharmaceutics

Volumn 3, Issue 6, 2006, Pages 756-761

  Groen, Annemiek ^a   Kunne, Cindy ^a   Oude Elferink, Ronald P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atp8b1; Bile acids; Bile salts; Coprophagy; Mouse

Indexed keywords

AMINOTRANSFERASE; BILE SALT; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; DIHYDROXYBILE SALT; UNCLASSIFIED DRUG;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; BILE COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; COPROPHAGY; DIET; FEEDING BEHAVIOR; INTESTINE ABSORPTION; MALE; METABOLIC ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ADMINISTRATION, ORAL; ANIMALS; BILE ACIDS AND SALTS; BODY WEIGHT; CHOLATES; COPROPHAGIA; FEEDING BEHAVIOR; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PORTAL VEIN; TRANSAMINASES;

EID: 33846128172     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060009t     Document Type: Article

References (17)

1. Torrallardona, D.; Harris, C. I.; Fuller, M. F. Microbial amino acid synthesis and utilization in rats: the role of coprophagy. Br. J. Nutr. 1996, 76 (5), 701-709.
2. Krief, S.; Jamart, A.; Hladik, C. M. On the possible adaptive value of coprophagy in free-ranging chimpanzees. Primates 2004, 45 (2), 141-145.
3. Negro, J. J.; Grande, J. M.; Tella, J. L.; Garrido, J.; Hornero, D.; Donazar, J. A.; Donazar, J. A. Sanchez-Zapata, J. A.; BenItez, J. R.; Barcell, M. Coprophagy: an unusual source of essential carotenoids. Nature 2002, 416 (6883), 807-808.
4. Shneider, B. L.; Dawson, P. A.; Christie, D. M.; Hardikar, W.; Wong, M. H.; Suchy, F. J. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J. Clin. Invest. 1995, 95 (2), 745-754.
5. Wong, M. H.; Oelkers, P.; Craddock, A. L.; Dawson, P. A. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J. Biol. Chem. 1994, 269 (2), 1340-1347.
6. Craddock, A. L.; Love, M. W.; Daniel, R. W.; Kirby L. C.; Walters, H. C.; Wong, M. H.; Dawson, P. A. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am. J. Physiol. 1998, 274 (1 Pt 1), 157-169.
7. Hofmann, A. F. The continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 1999, 159 (22), 2647-2658.
8. Bull, L. N.; Carlton, V. E.; Stricker, N. L.; Baharloo, S.; DeYoung, J. A.; Freimer, N. B.; Magid, M. S.; Kahn, E.; Markowitz, J.; DiCarlo, F. J.; McLoughlin, L.; Boyle, J. T.; Dahms, B. B.; Faught, P. R.; Fitzgerald, J. F.; Piccoli, D. A.; Witzleben, C. L.; O'Connell, N. C.; Setchell, K. D.; Agostini, R. M., Jr.; Kocoshis, S. A.; Reyes, J.; Knisely, A. S. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997, 26 (1), 155-164.
9. Chen, F.; Ananthanarayanan, M.; Emre, S.; Neimark, E.; Bull, L. N.; Knisely, A. S.; Strautnieks, S. S.; Thompson, R. J.; Magid, M. S.; Gordon, R.; Balasubramanian, N.; Suchy, F. J.; Shneider, B. L. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004, 126 (3), 756-764.
10. Pawlikowska, L.; Groen, A.; Eppens, E. F.; Kunne, C.; Ottenhoff, R.; Looije, N.; Knisely, A. S.; Killeen, N. P.; Bull, L. N.; Elferink, R. P.; Freimer, N. B. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum. Mol. Genet. 2004, 13 (8), 881-892.
11. Bootsma, A. H.; Overmars, H.; van Rooij, A.; van Lint, A. E.; Wanders, R. J.; van Gennip, A. H.; Vreken, P. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders. J. Inherited Metab. Dis. 1999, 22 (3), 307-310.
12. Noshiro, M.; Hayashi, S.; Murakami, K.; Okuda, K. The involvement of cytochrome b5 in 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol 25-hydroxylation and taurodeoxycholate 7 alpha-hydroxylation of rat liver. Biochem. Biophys. Res. Commun. 1982, 106 (3), 927-932.
13. Yamashita, H.; Kuroki, S.; Nakayama, F. Deoxycholate 7 alpha-hydroxylase in the hamster: substrate specificity and effect of phenobarbital. J. Lipid Res. 1989, 30 (5), 711-718.
14. Alvarez, L.; Jara, P.; Sanchez-Sabate, E.; Hierro, L.; Larrauri, J.; Diaz, M. C.; Camarena, C.; De la Vega, A.; Frauca, E.; Lopez-Collazo, E.; Lapunzina, P. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum. Mol. Genet. 2004, 13 (20), 2451-2460.
15. Yoshii, M.; Kihira, K.; Shoda, J.; Osuga, T.; Hoshita, T. Identification of 3,6,7,12-tetrahydroxy-5 beta-cholan-24-oic acids in human biologic fluids. Steroids 1990, 55 (11), 512-515.
16. Perwaiz, S.; Forrest, D.; Mignault, D.; Tuchweber, B.; Phillip, M. J.; Wang, R.; Ling, V.; Yousef, I. M. Appearance of atypical 3 alpha,6 beta,7 beta, 12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in spgp knockout mice. J. Lipid Res. 2003, 44 (3), 494-502.
17. Paulusma, C. C.; Groen, A.; Kunne, C.; Ho-Mok, K. S.; Spijkerboer, A. L.; de Waart, D. R.; Hoek, F. J.; Vreeling, H.; Hoeben, K. A.; van Marie, J.; Pawlikowska, L.; Bull, L. N.; Hofmann, A. F.; Knisely, A. S.; Oude Elferink, R. P. J. ATP8B1 deficiency reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006, 44, 195-204.